Product NDC: | 68382-106 |
Proprietary Name: | divalproex sodium |
Non Proprietary Name: | divalproex sodium |
Active Ingredient(s): | 125 mg/1 & nbsp; divalproex sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, COATED PELLETS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68382-106 |
Labeler Name: | Zydus Pharmaceuticals (USA) Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078919 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090127 |
Package NDC: | 68382-106-10 |
Package Description: | 1000 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-106-10) |
NDC Code | 68382-106-10 |
Proprietary Name | divalproex sodium |
Package Description | 1000 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-106-10) |
Product NDC | 68382-106 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | divalproex sodium |
Dosage Form Name | CAPSULE, COATED PELLETS |
Route Name | ORAL |
Start Marketing Date | 20090127 |
Marketing Category Name | ANDA |
Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
Substance Name | DIVALPROEX SODIUM |
Strength Number | 125 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |